NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways. - Kageyama K; Kikuchi E; Hoshino N; Ito M; Akiyama S; Shiba Y (The Journal of pharmacology and experimental therapeutics, 2026)